Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Organoids and Spheroids Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21330

Download Sample Report
Published On

July 2021

Total pages

153

About the Report

The global organoids market was valued over USD XX Bn in 2020 and is projected to expand at a CAGR of XX% during 2021-2027. Increase in incidence and prevalence of chronic and infectious diseases, adoption of organoids as therapeutics tools, application of organoids in drug discovery & personalized medicine, and use of organoids in research & development is anticipated to propel the global organoids market. The globe market is driven by the application of organoids as an important tool for cell biology, gene therapy, regenerative medicine, cancer research, and disease modelling. Technological advancements are expected to propel the global organoids market during the forecast period.

In 2019, Hubrecht Organoid Technology has entered into a strategic partnership with JSR Corporation to provide preclinical oncology drug development using organoid technology and to expand its European presence by opening a new organoid-focused operational site in Netherlands.

Based on the type, the global organoids and spheroids market is categorized into organoids and spheroids. In 2020, the spheroids market segment accounted for the largest revenue share. The high demand for such cell culture and its varied applicability in drug discovery, cancer biology, and in-vitro toxicology studies were its key segment drivers. Spheroids have a similar development pattern as that of cancer cells and could be re-cultured to produce similar cell copies, counted, morphologically measured through instruments.

Based on application, the development biology market segment held a major revenue share in the global organoids and spheroids market, in 2020. This high revenue share is due to the rising use of such culture systems in human developmental biology. Organoids are derived from the induced pluripotent stem cells (iPSCs), and embryonic stem cells, which are beneficial in the study of embryonic development, homeostasis, and pedigree analysis. These models are already being in use for studying the development processes of the brain, stomach, and pancreas through induction of bone morphogenetic protein, fibroblast growth factors, and WNT signaling pathways.

Based on the End User, Pharmaceutical and Biotechnological Industries segment held the largest share in 2019. This is owing to the factors such as rise in the potential clinical applications of organoids and spheroids, high utilization rate of organoids and spheroids in pre-clinical drug discovery by the key players, accelerated uptake of organoid and spheroid culture in the pharmaceutical research bodies, increase in the collaborations among the major players and rise in the pharmaceutical startups.

For a better understanding of the market penetration of the Organoids and Spheroids market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for disposable medical device sensor and generated revenue of USD XX million in 2020 owing to the presence of well-established players in the region, emerging investment in healthcare R&D by players etc., However, the Asia Pacific region would grow at the highest CAGR during the forecast period.

Some of the major players operating in the Organoids and Spheroids market are 3D BioMatrix, Hubrecht Organoid Technology (HUB), Kuraray, Prellis Biologics, Merck KGaA, 3D Biotek, STEMCELL Technologies Inc., Cellesce Ltd., Corning Incorporated, AMS Biotechnology Limited, Greiner Bio-One, InSphero/Perkin Elmer, Lonza, and Thermo Fisher Scientific, Inc.

The growing prevalence of chronic disorders in recent times has increased the demand for effective drugs. The organoids and spheroids model is increasingly becoming popular as they provide a better perspective for human developmental biology research. The organoids model reveals the effects of covid-19 on several intestinal cells. Thus, these models are playing a significant role in the vaccine development process. The rise in demand for diagnostics and therapeutics solutions for these chronic diseases is fuelling market growth. The organoids and spheroids are the three-dimensional structures that replicate the condition of different tissues present in the human body. The organoids model works as an in-vitro model for the study of biological development.

Scope of the Report

Products

The global organoids market was valued over USD XX Bn in 2020 and is projected to expand at a CAGR of XX% during 2021-2027.

Companies

3D BioMatrix, Hubrecht Organoid Technology (HUB), Kuraray, Prellis Biologics, Merck KGaA, 3D Biotek, STEMCELL Technologies Inc., Cellesce Ltd., Corning Incorporated, AMS Biotechnology Limited, Greiner Bio-One, InSphero/Perkin Elmer, Lonza, and Thermo Fisher Scientific, Inc.

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Global ORGANOIDS AND SPHEROIDS Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Global ORGANOIDS AND SPHEROIDS Market

2.1.1. Main Objective of the Global ORGANOIDS AND SPHEROIDS Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL ORGANOIDS AND SPHEROIDS MARKET REVENUE

7 MARKET INSIGHTS BY TYPE

7.1. Organoids

7.2. Spheroids

8 MARKET INSIGHTS BY APPLICATION

8.1. Developmental Biology

8.2. Regenerative Medicine

8.3. Personalized Medicine

8.4. Drug Toxicity

8.5. Efficacy Testing

9 MARKET INSIGHTS BY END USER

9.1. Biotechnology and Pharmaceutical Industries

9.2. Hospitals and Diagnostic Centers

9.3. Academic and Research Institutes

10 MARKET INSIGHTS BY REGION

10.1. North America ORGANOIDS AND SPHEROIDS Market

10.1.1. United States

10.1.2. Canada

10.1.3. Rest of North America

10.2. Europe ORGANOIDS AND SPHEROIDS Market

10.2.1. Germany

10.2.2. France

10.2.3. U.K.

10.2.4. Spain

10.2.5. Italy

10.2.6. Rest of Europe

10.3. Asia Pacific ORGANOIDS AND SPHEROIDS Market

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. Rest of the World ORGANOIDS AND SPHEROIDS Market

11 ORGANOIDS AND SPHEROIDS MARKET DYNAMICS

11.1. Market Drivers

11.2. Market Challenges

11.3. Impact Analysis

12 LEGAL & REGULATORY FRAMEWORK

13 DEMAND AND SUPPLY SIDE ANALYSIS

13.1. Demand Side Analysis

13.2. Supply Side Analysis

13.2.1. Top Product Launches

13.2.2. Top Business Partnerships

13.2.3. Top Merger & Acquisitions

14 VALUE CHAIN ANALYSIS

15 ORGANOIDS AND SPHEROIDS MARKET OPPORTUNITIES

16 ORGANOIDS AND SPHEROIDS MARKET TRENDS & INSIGHTS

17 COMPETITIVE SCENARIO

17.1. Porter's Five forces analysis

17.1.1. Bargaining power of Supplier

17.1.2. Bargaining power of Buyer

17.1.3. Industry Rivalry

17.1.4. Availability of Substitute

17.1.5. Threat of new Entrants

18 COMPANY PROFILED

18.1. Thermo Fisher Scientific, Inc.

18.1.1. Key Facts

18.1.2. Business Description

18.1.3. Key Product/Services Offerings

18.1.4. Growth Strategy

18.1.5. SWOT Analysis

18.1.6. Key Financials

18.1.6.1. Revenue Split

18.1.6.2. Financial Overview of Thermo Fisher Scientific, Inc.

18.1.7. Recent Developments

18.1.7.1. Product Launch

18.1.7.2. Partnerships

18.1.7.3. Business Expansion and Investments

18.1.7.4. Merger and Acquisition

18.2. Hubrecht Organoid Technology (HUB)

18.3. Kuraray

18.4. Prellis Biologics

18.5. Merck KGaA

18.6. 3D Biotek

18.7. STEMCELL Technologies Inc.

18.8. Cellesce Ltd.

18.9. Corning Incorporated

18.10. AMS Biotechnology Limited

19 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022